Better Care Advances Healthcare Technology with Partnership with Oracle

Better Care and Oracle have signed an agreement to collaborate on joint projects related to health data management, the companies announced in a statement. The aim of this joint participation is to “promote the alliance through various activities, reinforcing its position as a relevant player in healthcare management projects on an international scale.”

Among the benefits that this collaboration will bring is the possibility of storing health data in the cloud in an unlimited way and more securely than current physical servers. In this way, the data flow can be greater, access will be faster and health professionals will be able to expand information on diagnoses and treatments.

“This agreement will allow us to take advantage of the synergies between Better Care’s know-how in the collection and analysis of medical data and Oracle’s data management solutions, and will improve the work of healthcare centres in terms of efficiency and safety ,” adds Better Care’s CEO, Xavier García.

Better Care, based in Sabadell, currently operates in 35 hospitals in Europe

This alliance is relevant in a context marked by the recent green light given by the European Parliament to the provisional agreement to establish a European health data space, which will allow citizens to access their data electronically and health professionals to consult their medical records from any member state.

Outside of the agreement with Oracle, in the face of this scenario, Better Care has finalised its entry into the United States and expects to quadruple its revenues , up to five million euros.

Better Care currently operates in 35 hospitals in Europe and began operating in one in Canada last year, as PlantaDoce reported . The company also manages the license for 4,000 beds and plans to close 2024 with more than 6,000 beds . With its imminent entry into the United States, where it has already set up a subsidiary, the company will extend its presence to fifteen countries.

__

(Featured image by Florian Krumm via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.